Empresa Loxo Oncology Inc
Acciones
US5488621013
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 39 | 01/05/14 | |
President | - | - | |
Anthony Sireci
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Liz Beja
COO | Chief Operating Officer | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Compliance Officer | - | 01/04/18 | |
Human Resources Officer | - | - | |
Amy Rose
HRO | Human Resources Officer | - | 01/01/20 |
Philip Johnson
LAW | General Counsel | - | 01/11/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 30 614 536 | 29 481 314 ( 96,30 %) | 0 | 96,30 % |
Información de la empresa
Loxo Oncology, Inc.
281 Tresser Boulevard 9th floor
06901, Stamford
+203-653-3880
http://www.loxooncology.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,20 % | 103 mil M | |
+8,50 % | 101 mil M | |
+4,40 % | 23,07 mil M | |
-12,34 % | 22,23 mil M | |
-4,36 % | 18,05 mil M | |
-39,98 % | 17,18 mil M | |
-10,45 % | 16,94 mil M | |
+7,15 % | 14,07 mil M | |
+38,78 % | 12,35 mil M |